Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Rapid Anti-Suicidal Ideation Effects of Intravenous (IV) Ketamine in Hospitalized Patients

NCT01507181 is registered in ClinicalTrials.gov with James Murrough as lead sponsor.

NCT NCT01507181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01507181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Rapid Anti-Suicidal Ideation Effects of Intravenous (IV) Ketamine in Hospitalized Patients
Lead sponsor
James Murrough
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2012
Completion date
September 30, 2014
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

suicidal ideation